These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4723533)

  • 1. Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody.
    Rager-Zisman B; Allison AC
    J Gen Virol; 1973 Jun; 19(3):339-51. PubMed ID: 4723533
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus.
    Rager-Zisman B; Allison AC
    J Gen Virol; 1973 Jun; 19(3):329-38. PubMed ID: 4353212
    [No Abstract]   [Full Text] [Related]  

  • 3. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.
    Woodruff JF; Woodruff JJ
    J Immunol; 1974 Dec; 113(6):1726-34. PubMed ID: 4610045
    [No Abstract]   [Full Text] [Related]  

  • 4. Modification of severe coxsackievirus B 3 infection in marasmic mice by transfer of immune lymphoid cells.
    Woodruff JF; Woodruff JJ
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2108-11. PubMed ID: 5289370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetogenic properties of Coxsackie A13 and Coxsackie B4 viruses in experimental infection in mice].
    Bocharov EF; Shorin IuP; Solodovnikova IA; Kazarian LS; Seliatitskaia VG
    Vopr Virusol; 1988; 33(4):469-74. PubMed ID: 2848368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of Coxsackie-streptococcal infection].
    Kogut EP; Levashova NV; Bondarenko AP; Zherdeva AI; Shuvalova IA
    Vopr Virusol; 1978; (6):690-5. PubMed ID: 219625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental coxackievirus B 1 infection in immunologically altered mice.
    Petrovicová A
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(2):149-54. PubMed ID: 6309957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart disorder due to Coxsackie viruses B].
    Moravcová J; Ledec J; Kopecká D
    Vnitr Lek; 1973 Jul; 19(7):660-5. PubMed ID: 4726016
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of different temperatures on mortality, virus multiplication and interferon production in adult mice infected with Coxsackie B1 virus.
    Haahr S; Teisner B
    Arch Gesamte Virusforsch; 1973; 42(3):273-7. PubMed ID: 4754181
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antiviral properties of 4-iodoantipyrine in an experimental enterovirus infection].
    Iavorovskaia VE; Gritsenko LN; Petrov SA; Evstropov AN
    Vopr Virusol; 1994; 39(4):184-7. PubMed ID: 7998400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxsackievirus infection of mice. II. Viral kinetics and histopathological changes in mice experimentally infected with coxsackievirus B3 by intraperitoneal route.
    Vargová A; Bopegamage S; Borsanyiová M; Petrovicová A; Benkovicová M
    Acta Virol; 2003; 47(4):253-7. PubMed ID: 15068381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of Coxsackie A 10 virus infection in newborn and suckling mice of the strains A2G, ICR-K and CBA].
    Voiculescu C; Stanciu L; Rogoz S; Blaj-Băjeu S; Tomescu R; Tăţulescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(1):35-43. PubMed ID: 6154959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroral infection with group B coxsackievirus in the adult mouse: protective functions of the gut.
    Loria RM; Kibrick S; Broitman SA
    J Infect Dis; 1974 Nov; 130(5):539-43. PubMed ID: 4423592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-Coxsakie B viruses humoral immunity status in patients with pancreatic diseases].
    Trukhan DI
    Vopr Virusol; 2001; 46(2):33-6. PubMed ID: 11392968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity response of 3 animal species (guinea pigs, hamsters, mice) to various Coxsackie viruses of group A. II. Study of antibodies detected by gel immunodiffusion: comparison with complement fixing antibodies].
    Bringuier JP; Gaudin OG; Brigaud M; Terraillon J; Sohier R
    Ann Inst Pasteur (Paris); 1971 Oct; 121(4):551-61. PubMed ID: 5004043
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-coxsackie virus B3 myocardiopathy in mice.
    Feinstone SM; Hensley GT; Rytel MW
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):345-50. PubMed ID: 4589215
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental Coxsackie virus B-3 and B-4 myocarditis in mice.
    Kawai C; Matsumori A; Kumagai N; Tokuda M
    Jpn Circ J; 1978 Jan; 42(1):43-7. PubMed ID: 633597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persistent infection caused by the Coxsackie B3 virus in adult mice].
    Goriunova AG; Savinov AP
    Vopr Virusol; 1987; 32(2):213-6. PubMed ID: 3037797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis.
    Reyes MP; Lerner AM
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):333-8. PubMed ID: 1250870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.